| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.28 | 9e-13 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.23 | 4e-05 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.22 | 6e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-05 |